Posts

Decoding RaymondsIndex: Deterioration Risk Is a Question About Clocks, Not Companies

Image
On 14 August 2026, Korea's semi-annual reporting deadline closed. What surfaced afterward was not a new set of failing companies. It was a new set of observed ones. Ten bio and healthcare issuers received a disclaimer of opinion on their half-year statements — among them Kainos Medicine, Cellumed, Syntekabio, Enzychem Lifesciences, Rolling Stone, Eutilex, Celestra, EOFlow, Olipass and Korea Union Pharm (Edaily Pharm, 22 Aug 2026). On the main board, eleven KOSPI issuers filed non-clean half-year opinions and seventeen KOSDAQ issuers missed the deadline entirely (Ajunews, 19 Aug 2026). The number that matters for methodology is smaller: four . Kainos Medicine, Celestra, EOFlow and Olipass recorded negative total equity at the half-year mark — and under an amended listing rule, half-year negative equity became a listing-eligibility review trigger for the first time, applied to H1 2026 reports. Read that carefully. The companies did not deteriorate in August. Their equity had bee...
Post a Comment
Read more

When the Network Becomes Destiny: The Samsung–SK hynix Payout Split and the Hub Collapse Path

Image
In the space of three days in August 2026, the two companies that anchor Korea's equity market announced the largest shareholder returns in the country's history — and chose opposite instruments to deliver them. On 19 August, SK hynix's board approved the repurchase and full cancellation of ₩40 trillion of its own shares: roughly 24.07 million shares, about 3.3% of the 730,492,365 outstanding, priced off the prior close of ₩1,662,000. It is the largest cancellation ever undertaken by a Korean listed company. The board also moved its shareholder return target for 2025–2027 from "within 50% of cumulative free cash flow" to "over 50%." Two days later, Samsung Electronics approved a 2026 return of ₩90–110 trillion — about five times its previous record of ₩20.3 trillion set in 2020 — weighted toward dividends, with roughly ₩30 trillion in third-quarter cash dividends and a separate ₩15 trillion buyback for employee compensation. The instrument is a readou...
Post a Comment
Read more

What Individual Investors Don't See Until It's Too Late: The Advisory Layer

Image
On 26 August 2026, Korea's joint task force on stock manipulation — a standing body formed by the Financial Services Commission, the Financial Supervisory Service and the Korea Exchange — sent investigators to an accounting firm in Seocho-gu, Seoul. The target was not a listed company under audit. It was Hanmi Accounting Corporation itself. According to Edaily's report that evening, investigators believe several accountants at the firm traded on non-public information they encountered while performing audit and advisory work. The information is said to have included tender-offer timetables — the calendar of a corporate action, before that calendar reached the market. Alleged gains are described as running to hundreds of millions of won per person. Nothing has been adjudicated; these are allegations, and the firm has not been found to have done anything. Set the guilt question aside. What makes this case worth a Friday is where it happened. Information does not begin at the ...
Post a Comment
Read more

The Zombie Pattern: When the Only Capital Event Left Is the Sale Itself

Image
On the evening of 25 August 2026, a Korean department store operator disclosed that the sale of its controlling stake had been terminated. The buyer had not paid ₩7bn of an ₩8bn instalment. The next morning the shares opened 26% lower, at ₩3,165 — against the ₩8,000 a share the contract had specified six weeks earlier. The arithmetic of the deal is worth laying out, because it is unusually legible. On 15 July, the chairman and six others agreed to transfer 2,795,743 shares, 25.82% of the company, for ₩22,365,944,000. The structure had three parts: an up-front portion, a second instalment of ₩8bn, and a closing payment of ₩11,965,944,000 due 8 September. Subtract the second instalment and the closing payment from the total and the up-front portion works out to ₩2.4bn. On 21 August — 37 days into the contract — the buyer's position was reassigned to a different party and the payment calendar was rewritten. Four days after that, the deal was dead. What reinvestment intensity is act...
Post a Comment
Read more

Follow the Cash: The Day a Shareholder Had to Price a Look at the Ledger

Image
On 25 August 2026, Gabia — a KOSDAQ-listed hosting and cloud company — disclosed that Align Partners Capital Management and one other applicant had filed for an injunction at the Anyang branch of the Suwon District Court. The case number is 2026카합10135. The relief sought is unusually concrete: thirty days of access to the company's accounting books and records at its head office, starting three business days after the ruling is served; permission to bring lawyers and certified public accountants along; and ₩5 million for every day the company fails to comply. The application was filed on 10 August. Per the company's own disclosure, it was served on 25 August. Gabia says it will respond through legal procedure. What makes this worth a Wednesday column is not the dispute. It is what the dispute reveals about where public data ends. The request moved. Six months earlier, in February, the same fund had asked for something far smaller. It submitted a recommendatory shareholder ...
Post a Comment
Read more

The Capital Efficiency Signal: When Money Moves and Assets Don't

Image
On 24 August, a KOSDAQ-listed rare-earth magnet company called JS Link filed a routine-looking disclosure. It will repurchase ₩5.05bn of face value on its 14th private convertible bond — half of a ₩10.1bn issue — by exercising the issuer's own call option. Settlement is 1 September, off-market. The actual outlay, principal plus interest, is ₩5,331,992,000, and the filing states the source of funds in three characters: internal cash . The notes were issued on 1 August 2025. They mature on 1 August 2028. The company is buying them back at month thirteen of a thirty-six-month instrument. Both of the obvious readings are defensible. One says this is deleveraging: retiring conversion rights removes dilution pressure, and Korean market coverage earlier this year flagged the potential overhang from this issuer's convertibles as something to watch. The other says a company with eight consecutive years of operating losses — ₩19.3bn of revenue against ₩12.3bn of operating loss in 2025...
Post a Comment
Read more

This Week's Risk Radar: The Number That Flips Sign Depending on Where You Stand

Image
On 19 August, a small KOSDAQ manufacturer disclosed that its largest-shareholder block had changed hands. The filing was unusually bare. Purpose of acquisition: not applicable. Source of funds: not applicable. Plans to appoint or remove officers: not applicable. Reason for change: commencement of inheritance following the death of the largest shareholder. DUOBACK (KOSDAQ 073190), an ergonomic-chair maker founded in 1987, had 44.10% of its shares held by its chief executive and five related parties — 5,278,486 shares, of which 4,351,102 (36.36%) stood in the chief executive's own name. He died on 17 August; two days later the company filed the change; the next morning trading was suspended pending a delisting eligibility review. Read that sequence carefully. The causal chain is not the obvious one. What actually halted the stock The company had lost money at the operating line every year since 2021 — roughly ₩3.2bn, ₩4.2bn, ₩3.9bn, ₩3.4bn and ₩3.0bn across FY2021–FY2025. Its ma...
Post a Comment
Read more